Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer
- PMID: 40534841
- PMCID: PMC12174421
- DOI: 10.3389/fgene.2025.1539090
Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer
Abstract
Introduction: Circadian rhythms are controlled by biological clocks regulated at the molecular level by a set of circadian genes operating through a negative feedback loop. These genes also regulate key biological processes, including cell proliferation, cell cycle, and apoptosis.
Methods: We investigated the role of circadian gene polymorphisms in the risk of differentiated thyroid cancer (DTC) and their interaction with DTC risk factors. Data were obtained from 463 DTC cases and 482 unrelated controls of European ancestry, selected from two population-based case-control studies conducted in France. Associations with 570 single nucleotide polymorphisms (SNPs) in 23 circadian genes were evaluated using multivariate logistic regression models. Gene- and pathway-level associations and gene-environment interactions were analyzed using the adaptive rank truncated product (ARTP) method.
Results and discussion: We found no significant association between DTC risk and circadian gene polymorphisms at the SNP, gene, or pathway levels. However, we observed statistically significant interactions between smoking status and SNPs rs11204897 (RORC) and rs1012477 (PER3), as well as with the PER3 gene and the overall circadian pathway. These results suggest that smoking status may modulate the association between DTC and polymorphisms in circadian genes. Further studies are needed to confirm these findings.
Keywords: case-control study; circadian rhythm; differentiated thyroid cancer; gene–environment interaction; pathway analysis.
Copyright © 2025 Berrandou, Cordina-Duverger, Mulot, Guizard, Schvartz, Laurent-Puig, Zidane, De Vathaire, Guénel and Truong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Similar articles
-
A common alteration in effort-based decision-making in apathy, anhedonia, and late circadian rhythm.Elife. 2025 Jun 16;13:RP96803. doi: 10.7554/eLife.96803. Elife. 2025. PMID: 40522113 Free PMC article.
-
Long-Term Survival Rate for Moroccan Patients with Differentiated Thyroid Cancer.Asian Pac J Cancer Prev. 2025 Mar 1;26(3):913-923. doi: 10.31557/APJCP.2025.26.3.913. Asian Pac J Cancer Prev. 2025. PMID: 40156408 Free PMC article.
-
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.J Parkinsons Dis. 2025 Jun;15(4):789-804. doi: 10.1177/1877718X251330993. Epub 2025 Apr 29. J Parkinsons Dis. 2025. PMID: 40302366
-
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis: A Meta-analysis.JAMA Dermatol. 2024 Aug 1;160(8):830-837. doi: 10.1001/jamadermatol.2024.1677. JAMA Dermatol. 2024. PMID: 38888917 Free PMC article.
-
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation.Target Oncol. 2025 May;20(3):445-466. doi: 10.1007/s11523-025-01146-4. Epub 2025 May 21. Target Oncol. 2025. PMID: 40397306 Free PMC article. Review.
References
-
- Benjamini Y., Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57 (1), 289–300. 10.1111/j.2517-6161.1995.tb02031.x - DOI
LinkOut - more resources
Full Text Sources